Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease. Academic Article uri icon

Overview

publication date

  • August 21, 2017

Identity

PubMed Central ID

  • PMC5563904

Scopus Document Identifier

  • 85027721661

Digital Object Identifier (DOI)

  • 10.1186/s12931-016-0491-8

PubMed ID

  • 28826397

Additional Document Info

volume

  • 18

issue

  • 1